Header Logo

Connection

ARNOLD DELA CRUZ PAULINO to Humans

Back to Details
This is a "connection" page, showing publications ARNOLD DELA CRUZ PAULINO has written about Humans.
ARNOLD DELA CRUZ PAULINO
Connection Strength
1.135
Humans
  1. The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma. Neuro Oncol. 2024 Oct 03; 26(10):1912-1920.
    View in: PubMed
    Score: 0.019
  2. Late-onset lymphopenia during radiation is associated with an increased risk of tumor recurrence in newly diagnosed pediatric medulloblastoma. Pediatr Blood Cancer. 2024 Jul; 71(7):e31022.
    View in: PubMed
    Score: 0.018
  3. Comprehensive radiotherapy for pediatric Ewing Sarcoma: Outcomes of a prospective proton study. Radiother Oncol. 2024 06; 195:110270.
    View in: PubMed
    Score: 0.018
  4. Renal function in abdominal neuroblastoma patients undergoing proton radiotherapy. Pediatr Blood Cancer. 2023 01; 70(1):e29981.
    View in: PubMed
    Score: 0.016
  5. Quantifying the risk and dosimetric variables of symptomatic brainstem injury after proton beam radiation in pediatric brain tumors. Neuro Oncol. 2022 09 01; 24(9):1571-1581.
    View in: PubMed
    Score: 0.016
  6. Late Effects of Craniospinal Irradiation Using Electron Spinal Fields for Pediatric Patients With Cancer. Int J Radiat Oncol Biol Phys. 2023 01 01; 115(1):164-173.
    View in: PubMed
    Score: 0.016
  7. Overall survival and secondary malignant neoplasms in children receiving passively scattered proton or photon craniospinal irradiation for medulloblastoma. Cancer. 2021 Oct 15; 127(20):3865-3871.
    View in: PubMed
    Score: 0.015
  8. Scoliosis in Children Treated With Photon Craniospinal Irradiation for Medulloblastoma. Int J Radiat Oncol Biol Phys. 2021 03 01; 109(3):712-717.
    View in: PubMed
    Score: 0.015
  9. Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2021 03 01; 109(3):718-725.
    View in: PubMed
    Score: 0.015
  10. Training and education of pediatric radiation oncologists: A survey from the 2019 Pediatric Radiation Oncology Society meeting. Pediatr Blood Cancer. 2020 10; 67(10):e28619.
    View in: PubMed
    Score: 0.014
  11. Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma. Pediatr Blood Cancer. 2019 11; 66(11):e27952.
    View in: PubMed
    Score: 0.013
  12. Efficacy of proton therapy in children with high-risk and locally recurrent neuroblastoma. Pediatr Blood Cancer. 2019 08; 66(8):e27786.
    View in: PubMed
    Score: 0.013
  13. Patterns of failure following proton beam therapy for head and neck rhabdomyosarcoma. Radiother Oncol. 2019 05; 134:143-150.
    View in: PubMed
    Score: 0.013
  14. Meta-analysis of the incidence and patterns of second neoplasms after photon craniospinal irradiation in children with medulloblastoma. Pediatr Blood Cancer. 2018 08; 65(8):e27095.
    View in: PubMed
    Score: 0.012
  15. Radiation pneumonitis in pediatric Hodgkin lymphoma patients receiving radiation therapy to the chest. Pract Radiat Oncol. 2018 Sep - Oct; 8(5):e364-e368.
    View in: PubMed
    Score: 0.012
  16. Ototoxicity and cochlear sparing in children with medulloblastoma: Proton vs. photon radiotherapy. Radiother Oncol. 2018 07; 128(1):128-132.
    View in: PubMed
    Score: 0.012
  17. Local therapy to distant metastatic sites in stage IV rhabdomyosarcoma. Pediatr Blood Cancer. 2018 Feb; 65(2).
    View in: PubMed
    Score: 0.012
  18. Radiotherapy Deferral in Medulloblastoma. JAMA Oncol. 2016 Dec 01; 2(12):1582.
    View in: PubMed
    Score: 0.011
  19. The promise of intensity modulated radiation therapy. Pediatr Blood Cancer. 2016 09; 63(9):1513-4.
    View in: PubMed
    Score: 0.011
  20. Long-term disease control and toxicity outcomes following surgery and intensity modulated radiation therapy (IMRT) in pediatric craniopharyngioma. Radiother Oncol. 2015 Feb; 114(2):224-9.
    View in: PubMed
    Score: 0.010
  21. Radiation therapy to the primary and postinduction chemotherapy MIBG-avid sites in high-risk neuroblastoma. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90(4):858-62.
    View in: PubMed
    Score: 0.009
  22. Comparison of supine and prone craniospinal irradiation in children with medulloblastoma. Pract Radiat Oncol. 2015 Mar-Apr; 5(2):93-8.
    View in: PubMed
    Score: 0.009
  23. Secondary glioblastoma multiform in a patient with CHARGE syndrome and prior radiation therapy for medulloblastoma. Pediatr Hematol Oncol. 2014 May; 31(4):366-8.
    View in: PubMed
    Score: 0.009
  24. Stereotactic body radiation therapy (SBRT) for an isolated bone metastasis in an adolescent male with nasopharyngeal carcinoma. Pediatr Blood Cancer. 2014 Aug; 61(8):1520.
    View in: PubMed
    Score: 0.009
  25. Therapeutic challenges in treating patients with fragile X syndrome and neoplasia. Pediatr Blood Cancer. 2013 Dec; 60(12):E153-6.
    View in: PubMed
    Score: 0.009
  26. Lymph node management in patients with paratesticular rhabdomyosarcoma: a population-based analysis. Cancer. 2013 Sep 01; 119(17):3228-33.
    View in: PubMed
    Score: 0.009
  27. Radiotherapy in metastatic ewing sarcoma. Am J Clin Oncol. 2013 Jun; 36(3):283-6.
    View in: PubMed
    Score: 0.009
  28. Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma. Cancer. 2013 Jul 15; 119(14):2654-9.
    View in: PubMed
    Score: 0.009
  29. Sinonasal teratocarcinosarcoma in an adolescent male. J Pediatr Hematol Oncol. 2012 Oct; 34(7):e304-7.
    View in: PubMed
    Score: 0.008
  30. Rhabdomyosarcoma arising in a previously irradiated field: an analysis of 43 patients. Int J Radiat Oncol Biol Phys. 2013 Mar 01; 85(3):598-603.
    View in: PubMed
    Score: 0.008
  31. Outcome of patients with pilocytic astrocytoma and leptomeningeal dissemination. Int J Radiat Oncol Biol Phys. 2012 Oct 01; 84(2):350-4.
    View in: PubMed
    Score: 0.008
  32. Impact of PET-CT on involved field radiotherapy design for pediatric Hodgkin lymphoma. Pediatr Blood Cancer. 2012 Jun; 58(6):860-4.
    View in: PubMed
    Score: 0.008
  33. Bifocal intracranial germinoma: a retrospective analysis of treatment outcomes in 20 patients and review of the literature. Int J Radiat Oncol Biol Phys. 2012 Mar 15; 82(4):1341-51.
    View in: PubMed
    Score: 0.008
  34. Characteristics and outcome of radiation and chemotherapy-related mucoepidermoid carcinoma of the salivary glands. Pediatr Blood Cancer. 2011 Dec 15; 57(7):1137-41.
    View in: PubMed
    Score: 0.007
  35. Local control after craniospinal irradiation, intensity-modulated radiotherapy boost, and chemotherapy in childhood medulloblastoma. Cancer. 2011 Feb 01; 117(3):635-41.
    View in: PubMed
    Score: 0.007
  36. Height impairment after lower dose cranial irradiation in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2011 Feb; 56(2):279-81.
    View in: PubMed
    Score: 0.007
  37. Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma. Int J Radiat Oncol Biol Phys. 2010 Dec 01; 78(5):1445-50.
    View in: PubMed
    Score: 0.007
  38. Prognostic factors after extraneural metastasis of medulloblastoma. Int J Radiat Oncol Biol Phys. 2010 Sep 01; 78(1):72-8.
    View in: PubMed
    Score: 0.007
  39. Normal tissue development, homeostasis, senescence, and the sensitivity to radiation injury across the age spectrum. Semin Radiat Oncol. 2010 Jan; 20(1):12-20.
    View in: PubMed
    Score: 0.007
  40. Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk? Pediatr Blood Cancer. 2009 Dec 15; 53(7):1332-3.
    View in: PubMed
    Score: 0.007
  41. The impact of radiotherapy fields in the treatment of patients with choroid plexus carcinoma. Int J Radiat Oncol Biol Phys. 2010 Sep 01; 78(1):79-84.
    View in: PubMed
    Score: 0.007
  42. The carotid artery: an organ at risk and often neglected. Pediatr Blood Cancer. 2009 Oct; 53(4):529-30.
    View in: PubMed
    Score: 0.007
  43. The influence of pretreatment characteristics and radiotherapy parameters on time interval to development of radiation-associated meningioma. Int J Radiat Oncol Biol Phys. 2009 Dec 01; 75(5):1408-14.
    View in: PubMed
    Score: 0.006
  44. Renal toxicity in children undergoing total body irradiation for bone marrow transplant. Radiother Oncol. 2009 Feb; 90(2):242-6.
    View in: PubMed
    Score: 0.006
  45. Stereotactic body radiotherapy in the management of painful bone metastases. Oncology (Williston Park). 2008 Jun; 22(7):782-8; discussion 788-9, 796-7.
    View in: PubMed
    Score: 0.006
  46. Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):173-7.
    View in: PubMed
    Score: 0.006
  47. Radiation-induced malignant gliomas: is there a role for reirradiation? Int J Radiat Oncol Biol Phys. 2008 Aug 01; 71(5):1381-7.
    View in: PubMed
    Score: 0.006
  48. Intensity-modulated radiation therapy in childhood ependymoma. Int J Radiat Oncol Biol Phys. 2008 Jul 15; 71(4):987-93.
    View in: PubMed
    Score: 0.006
  49. Rhabdomyosarcoma. Curr Probl Cancer. 2008 Jan-Feb; 32(1):7-34.
    View in: PubMed
    Score: 0.006
  50. Supine craniospinal irradiation using intrafractional junction shifts and field-in-field dose shaping: early experience at Methodist Hospital. Int J Radiat Oncol Biol Phys. 2008 Jun 01; 71(2):477-83.
    View in: PubMed
    Score: 0.006
  51. American College of Radiology in-training examination for residents in radiation oncology (2004-2007). Int J Radiat Oncol Biol Phys. 2008 Mar 01; 70(3):666-70.
    View in: PubMed
    Score: 0.006
  52. Dose response and local control using radiotherapy in non-metastatic Ewing sarcoma. Pediatr Blood Cancer. 2007 Aug; 49(2):145-8.
    View in: PubMed
    Score: 0.006
  53. An analysis of primary site control and late effects according to local control modality in non-metastatic Ewing sarcoma. Pediatr Blood Cancer. 2007 Apr; 48(4):423-9.
    View in: PubMed
    Score: 0.006
  54. Comparison of conventional to intensity modulated radiation therapy for abdominal neuroblastoma. Pediatr Blood Cancer. 2006 Jun; 46(7):739-44.
    View in: PubMed
    Score: 0.005
  55. Collins' law revisited: can we reliably predict the time to recurrence in common pediatric tumors? Pediatr Hematol Oncol. 2006 Jan-Feb; 23(1):81-6.
    View in: PubMed
    Score: 0.005
  56. Treatment of brain tumors. N Engl J Med. 2005 Jun 02; 352(22):2350-3; author reply 2350-3.
    View in: PubMed
    Score: 0.005
  57. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2005 Apr 01; 61(5):1385-92.
    View in: PubMed
    Score: 0.005
  58. Risk factors for scoliosis in children with neuroblastoma. Int J Radiat Oncol Biol Phys. 2005 Mar 01; 61(3):865-9.
    View in: PubMed
    Score: 0.005
  59. Secondary neoplasms after radiotherapy for a childhood solid tumor. Pediatr Hematol Oncol. 2005 Mar; 22(2):89-101.
    View in: PubMed
    Score: 0.005
  60. The role of PET-CT fusion in head and neck cancer. Oncology (Williston Park). 2005 Feb; 19(2):241-6; dicussion 246, 249-50, 253.
    View in: PubMed
    Score: 0.005
  61. The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer. 2004 Dec 01; 101(11):2641-9.
    View in: PubMed
    Score: 0.005
  62. The value of postoperative radiotherapy in childhood nonrhabdomyosarcoma soft tissue sarcoma. Pediatr Blood Cancer. 2004 Oct; 43(5):587-93.
    View in: PubMed
    Score: 0.005
  63. Late effects of radiotherapy for pediatric extremity sarcomas. Int J Radiat Oncol Biol Phys. 2004 Sep 01; 60(1):265-74.
    View in: PubMed
    Score: 0.005
  64. Evolution of Proton Radiation Therapy Brainstem Constraints on the Pediatric Proton/Photon Consortium Registry. Pract Radiat Oncol. 2024 Nov-Dec; 14(6):e507-e514.
    View in: PubMed
    Score: 0.005
  65. FDG-PET in radiotherapy treatment planning: Pandora's box? Int J Radiat Oncol Biol Phys. 2004 May 01; 59(1):4-5.
    View in: PubMed
    Score: 0.005
  66. Radiation Oncology Training in the Philippines: Bridging Gaps for Improved Cancer Care in Low- and Middle-Income Countries. JCO Glob Oncol. 2024 May; 10:e2300462.
    View in: PubMed
    Score: 0.005
  67. Travel-Time Disparities in Access to Proton Beam Therapy for Cancer Treatment. JAMA Netw Open. 2024 May 01; 7(5):e2410670.
    View in: PubMed
    Score: 0.005
  68. Bilateral Wilms tumor with anaplasia: A report from the Children's Oncology Group Study AREN0534. Pediatr Blood Cancer. 2024 Jul; 71(7):e30981.
    View in: PubMed
    Score: 0.005
  69. Treatment options for children with nonrhabdomyosarcoma soft tissue sarcoma. Expert Rev Anticancer Ther. 2004 Apr; 4(2):247-56.
    View in: PubMed
    Score: 0.005
  70. Synovial sarcoma prognostic factors and patterns of failure. Am J Clin Oncol. 2004 Apr; 27(2):122-7.
    View in: PubMed
    Score: 0.005
  71. Patterns of failure in relation to radiotherapy fields in supratentorial primitive neuroectodermal tumor. Int J Radiat Oncol Biol Phys. 2004 Mar 15; 58(4):1171-6.
    View in: PubMed
    Score: 0.005
  72. Treatment and outcomes of clear cell sarcoma of the kidney: A report from the Children's Oncology Group studies AREN0321 and AREN03B2. Cancer. 2024 Jul 01; 130(13):2361-2371.
    View in: PubMed
    Score: 0.005
  73. Brain and Brain Stem Necrosis After Reirradiation for Recurrent Childhood Primary Central Nervous System Tumors: A PENTEC Comprehensive Review. Int J Radiat Oncol Biol Phys. 2024 Jun 01; 119(2):655-668.
    View in: PubMed
    Score: 0.005
  74. Biodevelopmental Considerations in Pediatric Patients With Cancer and Childhood Cancer Survivors: A PENTEC Introductory Review. Int J Radiat Oncol Biol Phys. 2024 Jun 01; 119(2):354-359.
    View in: PubMed
    Score: 0.004
  75. Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children's Oncology Group Studies AREN03B2 and AREN0532. Cancer. 2024 03 01; 130(5):792-802.
    View in: PubMed
    Score: 0.004
  76. Brain metastasis in children with sarcoma, neuroblastoma, and Wilms' tumor. Int J Radiat Oncol Biol Phys. 2003 Sep 01; 57(1):177-83.
    View in: PubMed
    Score: 0.004
  77. The role of surgery in recurrent ependymomas. J Neurosurg Pediatr. 2023 11 01; 32(5):584-589.
    View in: PubMed
    Score: 0.004
  78. Local control of parameningeal rhabdomyosarcoma: outcomes in non-complete responders to chemoradiation. Med Pediatr Oncol. 2003 Aug; 41(2):118-22.
    View in: PubMed
    Score: 0.004
  79. Patterns of failure after IMRT for head-and- neck cancer: let's not count the chickens before the eggs hatch. Int J Radiat Oncol Biol Phys. 2003 Aug 01; 56(5):1508; author reply 1508.
    View in: PubMed
    Score: 0.004
  80. Children's Oncology Group's 2023 blueprint for research: Radiation oncology. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30593.
    View in: PubMed
    Score: 0.004
  81. Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experience. J Neurooncol. 2023 Jul; 163(3):717-726.
    View in: PubMed
    Score: 0.004
  82. Multi-institutional Characterization of Outcomes for Pediatric and Young Adult Patients With High-Risk Myxopapillary Ependymoma After Radiation Therapy. Int J Radiat Oncol Biol Phys. 2023 Dec 01; 117(5):1174-1180.
    View in: PubMed
    Score: 0.004
  83. Role of fusion in radiotherapy treatment planning. Semin Nucl Med. 2003 Jul; 33(3):238-43.
    View in: PubMed
    Score: 0.004
  84. Long-term survival in a child with extraneural metastasis from medulloblastoma treated with chemo-radiotherapy. Med Pediatr Oncol. 2003 Jun; 40(6):396-7.
    View in: PubMed
    Score: 0.004
  85. Influence of radiotherapy technique on incidental dose to the whole ventricular system in focal irradiation of nongerminomatous germcell tumours. Acta Oncol. 2023 05; 62(5):503-507.
    View in: PubMed
    Score: 0.004
  86. Radiotherapy for Atypical Teratoid/Rhabdoid Tumor (ATRT) on the Pediatric Proton/Photon Consortium Registry (PPCR). J Neurooncol. 2023 Apr; 162(2):353-362.
    View in: PubMed
    Score: 0.004
  87. Resection cavity auto-contouring for patients with pediatric medulloblastoma using only CT information. J Appl Clin Med Phys. 2023 Jul; 24(7):e13956.
    View in: PubMed
    Score: 0.004
  88. Palliative radiotherapy in children with neuroblastoma. Pediatr Hematol Oncol. 2003 Mar; 20(2):111-7.
    View in: PubMed
    Score: 0.004
  89. Impact of Age on Overall Survival Among Children With Wilms Tumor: A Population-based Registry Analysis. Am J Clin Oncol. 2023 05 01; 46(5):213-218.
    View in: PubMed
    Score: 0.004
  90. Comparison of neurocognitive and quality-of-life outcomes in pediatric craniopharyngioma patients treated with partial resection and radiotherapy versus gross-total resection only. J Neurosurg Pediatr. 2023 05 01; 31(5):453-462.
    View in: PubMed
    Score: 0.004
  91. Protracted radiotherapy treatment duration in medulloblastoma. Am J Clin Oncol. 2003 Feb; 26(1):55-9.
    View in: PubMed
    Score: 0.004
  92. Automating the treatment planning process for 3D-conformal pediatric craniospinal irradiation therapy. Pediatr Blood Cancer. 2023 03; 70(3):e30164.
    View in: PubMed
    Score: 0.004
  93. Superior verbal learning and memory in pediatric brain tumor survivors treated with proton versus photon radiotherapy. Neuropsychology. 2023 Feb; 37(2):204-217.
    View in: PubMed
    Score: 0.004
  94. Harmonica consensus, controversies, and future directions in radiotherapy for pediatric Wilms tumors. Pediatr Blood Cancer. 2023 05; 70 Suppl 2:e30090.
    View in: PubMed
    Score: 0.004
  95. Current multimodality management of medulloblastoma. Curr Probl Cancer. 2002 Nov-Dec; 26(6):317-56.
    View in: PubMed
    Score: 0.004
  96. A novel case of malignant ossifying fibromyxoid tumor with a BCOR internal tandem duplication in a child. Pediatr Blood Cancer. 2023 03; 70(3):e29972.
    View in: PubMed
    Score: 0.004
  97. Development and validation of a population-based anatomical colorectal model for radiation dosimetry in late effects studies of survivors of childhood cancer. Radiother Oncol. 2022 11; 176:118-126.
    View in: PubMed
    Score: 0.004
  98. Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy. Int J Radiat Oncol Biol Phys. 2002 Jul 01; 53(3):543-7.
    View in: PubMed
    Score: 0.004
  99. Radiotherapeutic management of intracranial ependymoma. Pediatr Hematol Oncol. 2002 Jul-Aug; 19(5):295-308.
    View in: PubMed
    Score: 0.004
  100. Predicting neurocognitive function in pediatric brain tumor early survivorship: The neurological predictor scale and the incremental validity of tumor size. Pediatr Blood Cancer. 2022 09; 69(9):e29803.
    View in: PubMed
    Score: 0.004
  101. Induction chemotherapy and involved-field radiotherapy for intracranial germinoma. J Clin Oncol. 2002 Jun 15; 20(12):2911; author reply 2911-2.
    View in: PubMed
    Score: 0.004
  102. ASO Video Abstract: Kidney Preservation and Wilms Tumor Development in Children with Diffuse Hyperplastic Perilobar Nephroblastomatosis-A Report from the Children's Oncology Group Study AREN0534. Ann Surg Oncol. 2022 05; 29(5):3262-3263.
    View in: PubMed
    Score: 0.004
  103. Outcomes based on histopathologic response to preoperative chemotherapy in children with bilateral Wilms tumor: A prospective study (COG AREN0534). Cancer. 2022 07 01; 128(13):2493-2503.
    View in: PubMed
    Score: 0.004
  104. Intracranial ependymomas: an analysis of prognostic factors and patterns of failure. Am J Clin Oncol. 2002 Apr; 25(2):117-22.
    View in: PubMed
    Score: 0.004
  105. Locoregional control in infants with neuroblastoma: role of radiation therapy and late toxicity. Int J Radiat Oncol Biol Phys. 2002 Mar 15; 52(4):1025-31.
    View in: PubMed
    Score: 0.004
  106. Cognitive predictors of social adjustment in pediatric brain tumor survivors treated with photon versus proton radiation therapy. Pediatr Blood Cancer. 2022 06; 69(6):e29645.
    View in: PubMed
    Score: 0.004
  107. Kidney Preservation and Wilms Tumor Development in Children with Diffuse Hyperplastic Perilobar Nephroblastomatosis: A Report from the Children's Oncology Group Study AREN0534. Ann Surg Oncol. 2022 May; 29(5):3252-3261.
    View in: PubMed
    Score: 0.004
  108. Intensity-modulated radiation therapy in the treatment of children. Med Dosim. 2002; 27(2):115-20.
    View in: PubMed
    Score: 0.004
  109. Factors Associated With Acute Toxicity in Pediatric Patients Treated With Proton Radiation Therapy: A Report From the Pediatric Proton Consortium Registry. Pract Radiat Oncol. 2022 Mar-Apr; 12(2):155-162.
    View in: PubMed
    Score: 0.004
  110. Variation in Proton Craniospinal Irradiation Practice Patterns in the United States: A Pediatric Proton Consortium Registry (PPCR) Study. Int J Radiat Oncol Biol Phys. 2022 03 15; 112(4):901-912.
    View in: PubMed
    Score: 0.004
  111. Comparison of hypothyroidism, growth hormone deficiency, and adrenal insufficiency following proton and photon radiotherapy in children with medulloblastoma. J Neurooncol. 2021 Oct; 155(1):93-100.
    View in: PubMed
    Score: 0.004
  112. Amiodarone and radiation therapy sequelae. Am J Clin Oncol. 2001 Aug; 24(4):379-81.
    View in: PubMed
    Score: 0.004
  113. Relapsed Wilms tumor: is there a role for radiation therapy? Am J Clin Oncol. 2001 Aug; 24(4):408-13.
    View in: PubMed
    Score: 0.004
  114. Adjuvant chemotherapy for ependymoma: is it necessary for all children under five years of age? J Clin Oncol. 2001 Aug 01; 19(15):3588-9.
    View in: PubMed
    Score: 0.004
  115. Durable Response to Larotrectinib in a Child With Histologic Diagnosis of Recurrent Disseminated Ependymoma Discovered to Harbor an NTRK2 Fusion: The Impact of Integrated Genomic Profiling. JCO Precis Oncol. 2021; 5.
    View in: PubMed
    Score: 0.004
  116. Ependymoma Presenting as a -Rim-Enhancing Lesion in the Brainstem. Pediatr Neurosurg. 2021; 56(5):455-459.
    View in: PubMed
    Score: 0.004
  117. Gadolinium is not necessary for surveillance MR imaging in children with chiasmatic-hypothalamic low-grade glioma. Pediatr Blood Cancer. 2021 10; 68(10):e29178.
    View in: PubMed
    Score: 0.004
  118. Long-term cognitive and academic outcomes among pediatric brain tumor survivors treated with proton versus photon radiotherapy. Pediatr Blood Cancer. 2021 09; 68(9):e29125.
    View in: PubMed
    Score: 0.004
  119. Salivary and Dental Complications in Childhood Cancer Survivors Treated With Radiation Therapy to the Head and Neck: A PENTEC Comprehensive Review. Int J Radiat Oncol Biol Phys. 2024 Jun 01; 119(2):467-481.
    View in: PubMed
    Score: 0.004
  120. Case series of diffuse extraneural metastasis in H3F3A mutant high-grade gliomas: Clinical, molecular phenotype and literature review. J Clin Neurosci. 2021 Jul; 89:405-411.
    View in: PubMed
    Score: 0.004
  121. Treatment age and neurocognitive outcomes following proton beam radiotherapy for pediatric low- and intermediate-grade gliomas. Pediatr Blood Cancer. 2021 08; 68(8):e29096.
    View in: PubMed
    Score: 0.004
  122. Early radiotherapy preserves vision in sporadic optic pathway glioma. Cancer. 2021 07 01; 127(13):2358-2367.
    View in: PubMed
    Score: 0.004
  123. Observed-to-expected incidence ratios of second malignant neoplasms after radiation therapy for medulloblastoma: A Surveillance, Epidemiology, and End Results analysis. Cancer. 2021 07 01; 127(13):2368-2375.
    View in: PubMed
    Score: 0.004
  124. Young Adult Populations Face Yet Another Barrier to Care With Insurers: Limited Access to Proton Therapy. Int J Radiat Oncol Biol Phys. 2021 08 01; 110(5):1496-1504.
    View in: PubMed
    Score: 0.004
  125. The local field in infratentorial ependymoma: does the entire posterior fossa need to be treated? Int J Radiat Oncol Biol Phys. 2001 Mar 01; 49(3):757-61.
    View in: PubMed
    Score: 0.004
  126. Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma. J Clin Oncol. 2021 03 01; 39(7):807-821.
    View in: PubMed
    Score: 0.004
  127. Patterns of care for pediatric patients with newly-diagnosed grade II gliomas. Childs Nerv Syst. 2021 05; 37(5):1563-1572.
    View in: PubMed
    Score: 0.004
  128. Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2000 Dec 01; 48(5):1489-95.
    View in: PubMed
    Score: 0.004
  129. Radiotherapy and Late Effects. Pediatr Clin North Am. 2020 12; 67(6):1051-1067.
    View in: PubMed
    Score: 0.004
  130. Development and validation of an age-scalable cardiac model with substructures for dosimetry in late-effects studies of childhood cancer survivors. Radiother Oncol. 2020 12; 153:163-171.
    View in: PubMed
    Score: 0.004
  131. Comparison of posterior fossa and tumor bed boost in medulloblastoma. Am J Clin Oncol. 2000 Oct; 23(5):487-90.
    View in: PubMed
    Score: 0.004
  132. Wilms tumor. Pediatr Blood Cancer. 2021 05; 68 Suppl 2:e28257.
    View in: PubMed
    Score: 0.004
  133. Relationship between treatment center case volume and survival for localized Ewing sarcoma: The role of radiotherapy timing. Pediatr Blood Cancer. 2020 11; 67(11):e28685.
    View in: PubMed
    Score: 0.004
  134. Early evidence of pulmonary dysfunction in survivors of childhood Hodgkin lymphoma. Leuk Lymphoma. 2020 10; 61(10):2419-2427.
    View in: PubMed
    Score: 0.004
  135. A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study. Neuro Oncol. 2020 06 09; 22(6):875-885.
    View in: PubMed
    Score: 0.004
  136. The significance of radiotherapy treatment duration in intracranial ependymoma. Int J Radiat Oncol Biol Phys. 2000 Jun 01; 47(3):585-9.
    View in: PubMed
    Score: 0.004
  137. Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group. Cancer. 2020 08 01; 126(15):3516-3525.
    View in: PubMed
    Score: 0.004
  138. Development of second primary tumors and outcomes in medulloblastoma by treatment modality: A Surveillance, Epidemiology, and End Results analysis. Pediatr Blood Cancer. 2020 08; 67(8):e28373.
    View in: PubMed
    Score: 0.004
  139. Reply to S.A. Milgrom et al. J Clin Oncol. 2020 07 01; 38(19):2212-2213.
    View in: PubMed
    Score: 0.003
  140. A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma. Pediatr Blood Cancer. 2020 06; 67(6):e28283.
    View in: PubMed
    Score: 0.003
  141. Association of T and N Categories of the American Joint Commission on Cancer, 8th Edition, With Metastasis and Survival in Patients With Orbital Sarcoma. JAMA Ophthalmol. 2020 04 01; 138(4):374-381.
    View in: PubMed
    Score: 0.003
  142. Late effects in children treated with radiation therapy for Wilms' tumor. Int J Radiat Oncol Biol Phys. 2000 Mar 15; 46(5):1239-46.
    View in: PubMed
    Score: 0.003
  143. Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study. J Clin Oncol. 2020 05 10; 38(14):1558-1568.
    View in: PubMed
    Score: 0.003
  144. Posterior fossa boost in medulloblastoma: an analysis of dose to surrounding structures using 3-dimensional (conformal) radiotherapy. Int J Radiat Oncol Biol Phys. 2000 Jan 15; 46(2):281-6.
    View in: PubMed
    Score: 0.003
  145. Unresectable adenocarcinoma of the pancreas: patterns of failure and treatment results. Cancer Invest. 2000; 18(4):309-13.
    View in: PubMed
    Score: 0.003
  146. Effect of sensorineural hearing loss on neurocognitive and adaptive functioning in survivors of pediatric embryonal brain tumor. J Neurooncol. 2020 Jan; 146(1):147-156.
    View in: PubMed
    Score: 0.003
  147. Superior Intellectual Outcomes After Proton Radiotherapy Compared With Photon Radiotherapy for Pediatric Medulloblastoma. J Clin Oncol. 2020 02 10; 38(5):454-461.
    View in: PubMed
    Score: 0.003
  148. Cognitive mediators of adaptive functioning outcomes in survivors of pediatric brain tumors treated with proton radiotherapy. Pediatr Blood Cancer. 2020 02; 67(2):e28064.
    View in: PubMed
    Score: 0.003
  149. Malignant neoplasms after treatment for metachronous bilateral Wilms' tumor: a literature review. Pediatr Hematol Oncol. 1999 Nov-Dec; 16(6):533-8.
    View in: PubMed
    Score: 0.003
  150. An open invitation to join the Pediatric Proton/Photon Consortium Registry to standardize data collection in pediatric radiation oncology. Br J Radiol. 2020 Mar; 93(1107):20190673.
    View in: PubMed
    Score: 0.003
  151. Resected pancreatic cancer treated with adjuvant radiotherapy with or without 5-fluorouracil: treatment results and patterns of failure. Am J Clin Oncol. 1999 Oct; 22(5):489-94.
    View in: PubMed
    Score: 0.003
  152. Assembling the brain trust: the multidisciplinary imperative in neuro-oncology. Nat Rev Clin Oncol. 2019 08; 16(8):521-522.
    View in: PubMed
    Score: 0.003
  153. Re: Conservative surgical management of bilateral Wilms tumor: results of the United Kingdom Children's Cancer Study Group. J Urol. 1999 Jul; 162(1):167.
    View in: PubMed
    Score: 0.003
  154. Trilateral retinoblastoma: is the location of the intracranial tumor important? Cancer. 1999 Jul 01; 86(1):135-41.
    View in: PubMed
    Score: 0.003
  155. Medulloblastoma and supratentorial primitive neuroectodermal tumors: an institutional experience. Cancer. 1999 Jul 01; 86(1):142-8.
    View in: PubMed
    Score: 0.003
  156. Prospective, longitudinal comparison of neurocognitive change in pediatric brain tumor patients treated with proton radiotherapy versus surgery only. Neuro Oncol. 2019 06 10; 21(6):809-818.
    View in: PubMed
    Score: 0.003
  157. Successful treatment of metachronous contralateral intratubular germ cell neoplasia with partial orchiectomy and low-dose radiation in a patient previously treated for testicular carcinoma. Pediatr Blood Cancer. 2019 10; 66(10):e27872.
    View in: PubMed
    Score: 0.003
  158. Diffuse malignant leptomeningeal gliomatosis in a child: a case report and review of the literature. Am J Clin Oncol. 1999 Jun; 22(3):243-6.
    View in: PubMed
    Score: 0.003
  159. In Reply to Krishnatry and Manjali. Int J Radiat Oncol Biol Phys. 2019 06 01; 104(2):468-469.
    View in: PubMed
    Score: 0.003
  160. Adaptive functioning in pediatric brain tumor survivors: An examination of ethnicity and socioeconomic status. Pediatr Blood Cancer. 2019 09; 66(9):e27800.
    View in: PubMed
    Score: 0.003
  161. Increased risk of pseudoprogression among pediatric low-grade glioma patients treated with proton versus photon radiotherapy. Neuro Oncol. 2019 05 06; 21(5):686-695.
    View in: PubMed
    Score: 0.003
  162. The cranial-spinal junction in medulloblastoma: does it matter? Int J Radiat Oncol Biol Phys. 1999 Apr 01; 44(1):81-4.
    View in: PubMed
    Score: 0.003
  163. Controversies in the management of intracranial germinomas. Oncology (Williston Park). 1999 Apr; 13(4):513-21; discussion 521-2, 528-3.
    View in: PubMed
    Score: 0.003
  164. A Phase 1/2 Trial of Reirradiation for Diffuse Intrinsic Pontine Glioma. Int J Radiat Oncol Biol Phys. 2019 05 01; 104(1):144-148.
    View in: PubMed
    Score: 0.003
  165. Role of radiation therapy in parameningeal rhabdomyosarcoma. Cancer Invest. 1999; 17(3):223-30.
    View in: PubMed
    Score: 0.003
  166. Timing of Local Therapy Affects Survival in Ewing Sarcoma. Int J Radiat Oncol Biol Phys. 2019 05 01; 104(1):127-136.
    View in: PubMed
    Score: 0.003
  167. Hypothyroidism after craniospinal irradiation with proton or photon therapy in patients with medulloblastoma. Pediatr Hematol Oncol. 2018 May; 35(4):257-267.
    View in: PubMed
    Score: 0.003
  168. Patterns of proton therapy use in pediatric cancer management in 2016: An international survey. Radiother Oncol. 2019 03; 132:155-161.
    View in: PubMed
    Score: 0.003
  169. Endocrine Deficiency As a Function of Radiation Dose to the Hypothalamus and Pituitary in Pediatric and Young Adult Patients With Brain Tumors. J Clin Oncol. 2018 10 01; 36(28):2854-2862.
    View in: PubMed
    Score: 0.003
  170. Results of treatment of patients with maxillary sinus carcinoma. Cancer. 1998 Aug 01; 83(3):457-65.
    View in: PubMed
    Score: 0.003
  171. Prognostic Factors, Treatment, and Outcomes in Early Stage, Invasive Papillary Breast Cancer: A SEER Investigation of Less Aggressive Treatment in a Favorable Histology. Am J Clin Oncol. 2018 06; 41(6):532-537.
    View in: PubMed
    Score: 0.003
  172. Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study. J Clin Oncol. 2018 06 01; 36(16):1564-1570.
    View in: PubMed
    Score: 0.003
  173. The Children's Oncology Group Radiation Oncology Discipline: 15?Years of Contributions to the Treatment of Childhood Cancer. Int J Radiat Oncol Biol Phys. 2018 07 15; 101(4):860-874.
    View in: PubMed
    Score: 0.003
  174. Timing of Radiation Therapy in Pediatric Wilms Tumor: A Report From the National Cancer Database. Int J Radiat Oncol Biol Phys. 2018 06 01; 101(2):453-461.
    View in: PubMed
    Score: 0.003
  175. Regional Nodal Control for Head and Neck Alveolar Rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2018 05 01; 101(1):169-176.
    View in: PubMed
    Score: 0.003
  176. Metachronous bilateral Wilms' tumor: the importance of time interval to the development of a second tumor. Cancer. 1998 Jan 15; 82(2):415-20.
    View in: PubMed
    Score: 0.003
  177. Pediatric head and neck squamous cell carcinoma: Patient demographics, treatment trends and outcomes. Int J Pediatr Otorhinolaryngol. 2018 Mar; 106:21-25.
    View in: PubMed
    Score: 0.003
  178. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532. J Clin Oncol. 2018 01 20; 36(3):254-261.
    View in: PubMed
    Score: 0.003
  179. A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas. Pediatr Blood Cancer. 2018 Feb; 65(2).
    View in: PubMed
    Score: 0.003
  180. The location of the prostatic apex on retrograde urethrography and its relationship to the bottom of the ischial tuberosities. Am J Clin Oncol. 1997 Oct; 20(5):479-83.
    View in: PubMed
    Score: 0.003
  181. Is prophylactic neck irradiation indicated in patients with squamous cell carcinoma of the maxillary sinus? Int J Radiat Oncol Biol Phys. 1997 Sep 01; 39(2):283-9.
    View in: PubMed
    Score: 0.003
  182. Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology Group. Ann Surg. 2017 09; 266(3):470-478.
    View in: PubMed
    Score: 0.003
  183. Attention, processing speed, and executive functioning in pediatric brain tumor survivors treated with proton beam radiation therapy. Radiother Oncol. 2017 07; 124(1):89-97.
    View in: PubMed
    Score: 0.003
  184. Re: Is contralateral exploration of the kidney necessary in patients with Wilms tumor? J Urol. 1997 Jun; 157(6):2265.
    View in: PubMed
    Score: 0.003
  185. Radiotherapeutic management of medulloblastoma. Oncology (Williston Park). 1997 Jun; 11(6):813-23; discussion 823, 827-8, 831.
    View in: PubMed
    Score: 0.003
  186. Progression-free survival of children with localized ependymoma treated with intensity-modulated radiation therapy or proton-beam radiation therapy. Cancer. 2017 Jul 01; 123(13):2570-2578.
    View in: PubMed
    Score: 0.003
  187. Splenic irradiation in the palliation of patients with lymphoproliferative and myeloproliferative disorders. Am J Hosp Palliat Care. 1996 Nov-Dec; 13(6):32-5.
    View in: PubMed
    Score: 0.003
  188. Current issues in the diagnosis and management of Wilms' tumor. Oncology (Williston Park). 1996 Oct; 10(10):1553-65; discussion 1565-71.
    View in: PubMed
    Score: 0.003
  189. Local control in synchronous bilateral Wilms tumor. Int J Radiat Oncol Biol Phys. 1996 Oct 01; 36(3):541-8.
    View in: PubMed
    Score: 0.003
  190. Postoperative irradiation of patients with malignant tumors of skull base. Laryngoscope. 1996 Jul; 106(7):880-3.
    View in: PubMed
    Score: 0.003
  191. Gemcitabine-induced radiation recall myositis in a patient with relapsed nasopharyngeal carcinoma. Pract Radiat Oncol. 2017 Jan - Feb; 7(1):e19-e22.
    View in: PubMed
    Score: 0.003
  192. Paediatric radiation oncology in the care of childhood cancer: A position paper by the International Paediatric Radiation Oncology Society (PROS). Radiother Oncol. 2016 05; 119(2):357-60.
    View in: PubMed
    Score: 0.003
  193. Comparing Intelligence Quotient Change After Treatment With Proton Versus Photon Radiation Therapy for Pediatric Brain Tumors. J Clin Oncol. 2016 Apr 01; 34(10):1043-9.
    View in: PubMed
    Score: 0.003
  194. Comparison of CT- and FDG-PET-defined GT: in regard to Paulino et al. (Int J Radiat Oncol Biol Phys 2005;61:1385-1392). Int J Radiat Oncol Biol Phys. 2005 Sep 01; 63(1):308-9; author reply 309.
    View in: PubMed
    Score: 0.003
  195. Mucoepidermoid Carcinoma in Children: A Single Institutional Experience. Pediatr Blood Cancer. 2016 Jan; 63(1):27-31.
    View in: PubMed
    Score: 0.003
  196. Treatment of brain tumors. N Engl J Med. 2005 Jun 02; 352(22):2350-3; author reply 2350-3.
    View in: PubMed
    Score: 0.002
  197. Imaging Changes in Pediatric Intracranial Ependymoma Patients Treated With Proton Beam Radiation Therapy Compared to Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):54-63.
    View in: PubMed
    Score: 0.002
  198. Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):349-57.
    View in: PubMed
    Score: 0.002
  199. Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity. Int J Radiat Oncol Biol Phys. 2014 Oct 01; 90(2):354-61.
    View in: PubMed
    Score: 0.002
  200. Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast. Br J Cancer. 2014 Jul 29; 111(3):619-22.
    View in: PubMed
    Score: 0.002
  201. Is there an increase in genitourinary toxicity in patients treated with transurethral resection of the prostate and radiotherapy? A systematic review. Am J Clin Oncol. 2014 Jun; 37(3):297-304.
    View in: PubMed
    Score: 0.002
  202. Long-term outcome of centrally located low-grade glioma in children. Cancer. 2013 Jul 15; 119(14):2630-8.
    View in: PubMed
    Score: 0.002
  203. Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas. Neuro Oncol. 2013 Jun; 15(6):759-66.
    View in: PubMed
    Score: 0.002
  204. Salvage intensity modulated radiotherapy using endorectal balloon after radical prostatectomy: clinical outcomes. Int J Urol. 2013 Dec; 20(12):1178-83.
    View in: PubMed
    Score: 0.002
  205. Prognostic markers for invasive micropapillary carcinoma of the breast: a population-based analysis. Clin Breast Cancer. 2013 Apr; 13(2):133-9.
    View in: PubMed
    Score: 0.002
  206. Risks outweighed benefits from local radiation for non-stage 4 neuroblastoma. Int J Radiat Oncol Biol Phys. 2002 Dec 01; 54(5):1575; author reply 1575.
    View in: PubMed
    Score: 0.002
  207. Spontaneous regression of thoracic metastases while progression of brain metastases after stereotactic radiosurgery and stereotactic body radiotherapy for metastatic renal cell carcinoma: abscopal effect prevented by the blood-brain barrier? Clin Genitourin Cancer. 2012 Sep; 10(3):196-8.
    View in: PubMed
    Score: 0.002
  208. A dose-response relationship for time to bone pain resolution after stereotactic body radiotherapy (SBRT) for renal cell carcinoma (RCC) bony metastases. Acta Oncol. 2012 May; 51(5):584-8.
    View in: PubMed
    Score: 0.002
  209. Treatment trends and outcomes of small-cell carcinoma of the bladder. Int J Radiat Oncol Biol Phys. 2012 May 01; 83(1):64-70.
    View in: PubMed
    Score: 0.002
  210. A Surveillance, Epidemiology and End Results (SEER) program comparison of adult and pediatric Wilms' tumor. Cancer. 2012 May 01; 118(9):2541-51.
    View in: PubMed
    Score: 0.002
  211. Stereotactic body radiation therapy for prostate cancer. Future Oncol. 2011 Sep; 7(9):1077-86.
    View in: PubMed
    Score: 0.002
  212. A Surveillance, Epidemiology, and End Results analysis of small cell carcinoma of the bladder: epidemiology, prognostic variables, and treatment trends. Cancer. 2011 Dec 01; 117(23):5325-33.
    View in: PubMed
    Score: 0.002
  213. Stereotactic body radiation therapy (SBRT) for genitourinary malignancies. Discov Med. 2010 Sep; 10(52):255-62.
    View in: PubMed
    Score: 0.002
  214. Radiation-associated kidney injury. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3 Suppl):S108-15.
    View in: PubMed
    Score: 0.002
  215. Ureteral stenosis after postprostatectomy intensity-modulated radiotherapy. Am J Clin Oncol. 2010 Feb; 33(1):108.
    View in: PubMed
    Score: 0.002
  216. Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system. Technol Cancer Res Treat. 2009 Dec; 8(6):407-12.
    View in: PubMed
    Score: 0.002
  217. Helical tomotherapy significantly reduces dose to normal tissues when compared to 3D-CRT for locally advanced rectal cancer. Technol Cancer Res Treat. 2009 Oct; 8(5):379-85.
    View in: PubMed
    Score: 0.002
  218. Prostate-specific antigen bounce after intensity-modulated radiotherapy for prostate cancer. Urology. 2010 Sep; 76(3):728-33.
    View in: PubMed
    Score: 0.002
  219. Standardization of head and neck contouring using the acanthiomeatal line. Med Dosim. 2009; 34(3):225-7.
    View in: PubMed
    Score: 0.002
  220. [Recent developments in radiation oncology-integrating radiation physics and molecular radiobiology advances into clinical radiotherapy practice and beyond]. Ai Zheng. 2008 Aug; 27(8):885-93.
    View in: PubMed
    Score: 0.002
  221. Changes mimicking new leptomeningeal disease after intensity-modulated radiotherapy for medulloblastoma. Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):214-21.
    View in: PubMed
    Score: 0.002
  222. Role of total skin electron beam therapy for leukemia cutis in pediatric patients. Pediatr Blood Cancer. 2008 May; 50(5):1054-5.
    View in: PubMed
    Score: 0.002
  223. Versatility of the Novalis system to deliver image-guided stereotactic body radiation therapy (SBRT) for various anatomical sites. Technol Cancer Res Treat. 2007 Aug; 6(4):347-54.
    View in: PubMed
    Score: 0.001
  224. A single institution experience with pediatric nasopharyngeal carcinoma: high incidence of toxicity associated with platinum-based chemotherapy plus IMRT. J Pediatr Hematol Oncol. 2007 Jul; 29(7):500-5.
    View in: PubMed
    Score: 0.001
  225. Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery. Clin Genitourin Cancer. 2007 Jun; 5(5):334-7.
    View in: PubMed
    Score: 0.001
  226. What is the best adjuvant treatment for very young patients with medulloblastoma? Expert Rev Neurother. 2007 Apr; 7(4):373-81.
    View in: PubMed
    Score: 0.001
  227. Computer visualization techniques (CVTs) foster evidence-based target delineation. Cancer Invest. 2007 Feb; 25(1):1-5.
    View in: PubMed
    Score: 0.001
  228. Serial therapy-induced changes in tumor shape in cervical cancer and their impact on assessing tumor volume and treatment response. AJR Am J Roentgenol. 2006 Jul; 187(1):65-72.
    View in: PubMed
    Score: 0.001
  229. Radiation therapy in the management of brain metastases from renal cell carcinoma. Oncology (Williston Park). 2006 May; 20(6):603-13; discussion 613, 616, 619-20 passsim.
    View in: PubMed
    Score: 0.001
  230. Radiation-induced moyamoya syndrome. Int J Radiat Oncol Biol Phys. 2006 Jul 15; 65(4):1222-7.
    View in: PubMed
    Score: 0.001
  231. Scheduling for radiotherapy simulation in children with a renal mass. Pediatr Hematol Oncol. 2006 Apr-May; 23(3):275-6.
    View in: PubMed
    Score: 0.001
  232. Mantle fields in the era of dynamic multileaf collimation: field shaping and electronic tissue compensation. Med Dosim. 2006; 31(3):179-83.
    View in: PubMed
    Score: 0.001
  233. Reirradiation in the era of IMRT: a dream or reality? Am J Clin Oncol. 2005 Oct; 28(5):472-3.
    View in: PubMed
    Score: 0.001
  234. Radiation-induced osteosarcomas in the pediatric population. Int J Radiat Oncol Biol Phys. 2005 Nov 15; 63(4):1169-74.
    View in: PubMed
    Score: 0.001
  235. F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer. Head Neck. 2005 Jun; 27(6):494-502.
    View in: PubMed
    Score: 0.001
  236. In regard to Paulino and Johnstone: Use of PET and CT imaging data in radiation therapy planning. Int J Radit Oncol Biol Phys 2004;59:4-5. Int J Radiat Oncol Biol Phys. 2004 Nov 01; 60(3):1005-6; author reply 1006.
    View in: PubMed
    Score: 0.001
  237. Extra-target doses in children receiving multileaf collimator (MLC) based intensity modulated radiation therapy (IMRT). Pediatr Blood Cancer. 2004 Jun; 42(7):626-30.
    View in: PubMed
    Score: 0.001
  238. The effect of an extended source-to-skin distance in the treatment of the spinal field in children receiving craniospinal irradiation. Med Dosim. 2004; 29(1):7-10.
    View in: PubMed
    Score: 0.001
  239. Does prone positioning reduce small bowel dose in pelvic radiation with intensity-modulated radiotherapy for gynecologic cancer? Int J Radiat Oncol Biol Phys. 2003 Sep 01; 57(1):230-8.
    View in: PubMed
    Score: 0.001
  240. Locoregional treatment for adult soft tissue sarcomas of the head and neck: an institutional review. Cancer J. 2003 Jan-Feb; 9(1):49-57.
    View in: PubMed
    Score: 0.001
  241. Curative radiotherapy for primary orbital lymphoma. Int J Radiat Oncol Biol Phys. 2002 Nov 01; 54(3):818-23.
    View in: PubMed
    Score: 0.001
  242. Free tissue transfer versus pedicled flap cost in head and neck cancer. Otolaryngol Head Neck Surg. 2002 Sep; 127(3):205-12.
    View in: PubMed
    Score: 0.001
  243. Prognostic factors in head and neck rhabdomyosarcoma. Head Neck. 2002 May; 24(5):468-73.
    View in: PubMed
    Score: 0.001
  244. In vivo determination of extra-target doses received from serial tomotherapy. Radiother Oncol. 2002 May; 63(2):217-22.
    View in: PubMed
    Score: 0.001
  245. Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2002 Jan 01; 52(1):14-22.
    View in: PubMed
    Score: 0.001
  246. Esthesioneuroblastoma: the University of Iowa experience 1978-1998. Laryngoscope. 2001 Mar; 111(3):488-93.
    View in: PubMed
    Score: 0.001
  247. Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer. J Magn Reson Imaging. 2000 Dec; 12(6):1027-33.
    View in: PubMed
    Score: 0.001
  248. Magnetic resonance imaging in the assessment of radiation response in cervical cancer: regarding Hatano K et al. IJROBP 1999; 45:399-344. Int J Radiat Oncol Biol Phys. 2000 Oct 01; 48(3):910-2.
    View in: PubMed
    Score: 0.001
  249. Determination of the inferior border of the thecal sac using magnetic resonance imaging: implications on radiation therapy treatment planning. Int J Radiat Oncol Biol Phys. 1998 Jun 01; 41(3):621-4.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.